| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.001 | 1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00019 | 1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.00028 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00013 | 1 |